Nanopublication

< Home

ID

http://purl.org/np/RAvxGuz3o7uA48O-l5wUUrm_CEuuO9uG_YF3vI6O0918o

Formats

.trig | .trig.txt | .jelly | .jelly.txt | .jsonld | .jsonld.txt | .nq | .nq.txt | .xml | .xml.txt

Content

@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RAvxGuz3o7uA48O-l5wUUrm_CEuuO9uG_YF3vI6O0918o> .
@prefix sub: <http://purl.org/np/RAvxGuz3o7uA48O-l5wUUrm_CEuuO9uG_YF3vI6O0918o#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix orcid: <https://orcid.org/> .
@prefix nkg: <https://w3id.org/neurodkg/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_10933> schema:possibleTreatment sub:medtherapy;
    schema:signOrSymptom <http://purl.bioontology.org/ontology/MEDDRA/10010219>, <https://identifiers.org/MONDO:0001158> .
  
  sub:medtherapy prov:wasDerivedFrom sub:quote;
    schema:drug <http://identifiers.org/drugbank/DB00715>;
    schema:targetPopulation sub:targetpop;
    nkg:indicationType nkg:SymptomaticReliefIndication .
  
  sub:quote prov:value "Paroxetine tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD) as defined in the DSM-IV.";
    prov:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> .
  
  sub:targetpop schema:healthCondition <http://purl.obolibrary.org/obo/DOID_10933> .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
    npx:hasSignature "do5uPeUdmZU0WGIP5cb9oHMvdFNaOivyD75QyzMQqMtDN6XGZobUAZlU19lwSjci0VsXJMtzq8wj0T5i4hW4cJ2pAGkLT8790iP18YqU8LkIdZ97Kt3sTS/78VCXxlWjud9zMFrEb2mV4JM5znfxwOXBQ1f7sd6rvx+kmK5L/nI=";
    npx:hasSignatureTarget this: .
  
  this: dcterms:created "2021-04-17T12:04:17.896+02:00"^^xsd:dateTime;
    dcterms:creator orcid:0000-0002-1468-3557;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    nt:wasCreatedFromTemplate <http://purl.org/np/RA56KBJXCfPObqVb3hNCSbbohzz02_VEW2PxnmyIQ0Hus> .
}